Viewing Study NCT04289051


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-01-01 @ 4:17 PM
Study NCT ID: NCT04289051
Status: COMPLETED
Last Update Posted: 2022-02-24
First Post: 2020-02-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Clinical Evaluation of Oral Rinse for Xerostomia
Sponsor: Sunstar Americas
Organization:

Study Overview

Official Title: Clinical Evaluation of the Efficacy of an Intra Oral Rinse for Patients With Xerostomia
Status: COMPLETED
Status Verified Date: 2021-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Xerostomia causes a difficulty in eating, have irritated oral tissues, and a poor quality of life. The new oral rinse was designed to reduce the symptoms and improve the patient's quality of life. The objectives of the clinical study is to evaluate the effectiveness of the oral rinse comparing to the placebo product and the control product in the market.

This is a randomized double-blind placebo controlled crossover study with 39 patients receiving treatment. Patients will be randomly allocated to three treatment groups. Patients will use the assigned oral rinse four times a day for two weeks. Dry mouth symptoms and other endpoints will be assessed subjectively and objectively at baseline and Day 14. Patients will be assigned to another treatment after one week wash-out period.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?: